SGMT
Sagimet Biosciences Inc.
Company overview
- Market capitalization
- —
- Employees
- 16
- Latest publication
- 2026-09-29
About Sagimet Biosciences Inc.
Sagimet Biosciences Inc., a clinical-stage biopharmaceutical company, develops novel therapeutics called fatty acid synthase (FASN) inhibitors for the treatment of diseases that result from dysfunctional metabolic and fibrotic pathways in the United States. The company's lead drug candidate is Denifanstat, an oral, once-daily pill and selective FASN inhibitor for the treatment of metabolic dysfunction-associated steatohepatitis, acne, and select forms of cancer. It also develops TVB-3567, a FASN inhibitor for the treatment of acne indication; and other oncology programs, such as solid tumor and glioblastoma. The company was formerly known as 3-V Biosciences, Inc. and changed its name to Sagimet Biosciences Inc. in August 2019. Sagimet Biosciences Inc. was incorporated in 2006 and is headquartered in San Mateo, California.
Financial statements
Income Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Research Development | 6,995,000USD | 6,734,000USD | 9,730,000USD | 7,248,000USD | 15,342,000USD | 14,216,000USD | 12,653,000USD | 6,313,000USD |
| Selling General Administrative | 4,718,000USD | 4,031,000USD | 4,604,000USD | 4,677,000USD | 4,523,000USD | 3,979,000USD | 4,249,000USD | 4,276,000USD |
| Total Operating Expenses | 11,713,000USD | 10,765,000USD | 14,334,000USD | 11,925,000USD | 19,865,000USD | 18,195,000USD | 16,902,000USD | 10,589,000USD |
| Operating Income | -11,713,000USD | -10,765,000USD | -14,334,000USD | -11,925,000USD | -19,865,000USD | -18,195,000USD | -16,902,000USD | -10,589,000USD |
| Interest Income | 1,063,000USD | 1,197,000USD | 1,426,000USD | 1,539,000USD | 1,689,000USD | 1,994,000USD | 2,283,000USD | 2,471,000USD |
| Net Interest Income | 1,063,000USD | 1,197,000USD | 1,426,000USD | 1,539,000USD | 1,689,000USD | 1,994,000USD | 2,283,000USD | 2,471,000USD |
| Income Before Tax | -10,650,000USD | -9,568,000USD | -12,908,000USD | -10,386,000USD | -18,176,000USD | -16,201,000USD | -14,619,000USD | -8,118,000USD |
| Net Income | -10,650,000USD | -9,568,000USD | -12,908,000USD | -10,386,000USD | -18,176,000USD | -16,201,000USD | -14,619,000USD | -8,118,000USD |
| Net Income From Continuing Ops | -10,650,000USD | -9,568,000USD | -12,908,000USD | -10,386,000USD | -18,176,000USD | -16,201,000USD | -14,619,000USD | -8,118,000USD |
| Ebitda | -11,713,000USD | -12,191,000USD | -12,908,000USD | -11,925,000USD | -19,865,000USD | -16,201,000USD | -16,902,000USD | -10,589,000USD |
| Total Other Income Expense Net | 1,063,000USD | 1,197,000USD | 1,426,000USD | 1,539,000USD | 1,689,000USD | 1,994,000USD | 2,283,000USD | 2,471,000USD |
| Ebit | — | — | — | -11,925,000USD | -19,865,000USD | -18,195,000USD | -16,902,000USD | -21,178,000USD |
| Income Tax Expense | — | — | — | — | — | — | — | -10,589,000USD |
| Depreciation And Amortization | — | — | — | — | — | — | — | 10,589,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD |
|---|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 2,000,000USD | 0USD | 0USD | 0USD | 0USD |
| Research Development | 39,054,000USD | 38,444,000USD | 19,777,000USD | 24,919,000USD | 19,340,000USD | 8,182,000USD | 8,391,000USD |
| Selling General Administrative | 17,835,000USD | 16,010,000USD | 12,963,000USD | 6,136,000USD | 4,379,000USD | 3,218,000USD | 5,861,000USD |
| Total Operating Expenses | 56,889,000USD | 54,454,000USD | 32,740,000USD | 31,055,000USD | 23,719,000USD | 11,400,000USD | 14,071,000USD |
| Operating Income | -56,889,000USD | -54,454,000USD | -30,740,000USD | -31,055,000USD | -23,719,000USD | -11,400,000USD | -14,159,000USD |
| Interest Income | 5,851,000USD | 8,887,000USD | 1,739,000USD | 553,000USD | 26,000USD | 30,000USD | 128,000USD |
| Net Interest Income | 5,851,000USD | 8,887,000USD | 1,739,000USD | 553,000USD | 26,000USD | 30,000USD | 64,000USD |
| Income Before Tax | -51,038,000USD | -45,567,000USD | -27,876,000USD | -30,499,000USD | -24,442,000USD | -11,370,000USD | -14,261,000USD |
| Net Income | -51,038,000USD | -45,567,000USD | -27,876,000USD | -30,499,000USD | -24,442,000USD | -11,370,000USD | -14,261,000USD |
| Net Income From Continuing Ops | -51,038,000USD | -45,567,000USD | -26,920,000USD | -30,499,000USD | -24,442,000USD | -11,370,000USD | -14,261,000USD |
| Ebitda | -56,889,000USD | -45,567,000USD | -30,740,000USD | -31,055,000USD | -23,719,000USD | -11,399,000USD | -14,109,000USD |
| Total Other Income Expense Net | 5,851,000USD | 8,887,000USD | 2,864,000USD | 3,000USD | -749,000USD | 30,000USD | -102,000USD |
| Ebit | — | -54,454,000USD | -61,484,000USD | -31,055,000USD | -23,719,000USD | -11,400,000USD | -14,197,000USD |
| Gross Profit | — | — | 2,000,000USD | -130,000USD | -134,000USD | -124,000USD | -88,000USD |
| Income Tax Expense | — | — | -2,860,000USD | -31,608,000USD | -23,745,000USD | -176,297USD | -9,000USD |
| Depreciation And Amortization | — | — | 30,740,000USD | 31,055,000USD | 23,719,000USD | 1,000USD | 88,000USD |
| Cost Of Revenue | — | — | — | 130,000USD | 134,000USD | 124,000USD | 88,000USD |
| Interest Expense | — | — | — | — | — | 0USD | 64,000USD |
| Reconciled Depreciation | — | — | — | — | — | 0USD | 1,000USD |
| Net Income Applicable To Common Shares | — | — | — | — | — | -11,370,000USD | -14,261,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 107,755,000USD | 116,482,000USD | 128,401,000USD | 137,407,000USD | 146,172,000USD | 160,259,000USD | 174,775,000USD | 189,020,000USD |
| Other Current Assets | 3,177,000USD | 3,280,000USD | 2,540,000USD | 1,789,000USD | 1,503,000USD | 1,524,000USD | 4,704,000USD | 378,000USD |
| Total Liab | 5,297,000USD | 5,101,000USD | 9,146,000USD | 7,247,000USD | 7,180,000USD | 4,454,000USD | 4,092,000USD | 5,728,000USD |
| Total Stockholder Equity | 102,458,000USD | 111,381,000USD | 119,255,000USD | 130,160,000USD | 138,992,000USD | 155,805,000USD | 170,683,000USD | 183,292,000USD |
| Other Current Liab | 2,955,000USD | 3,714,000USD | 4,788,000USD | 5,174,000USD | 3,918,000USD | 2,951,000USD | 2,824,000USD | 3,581,000USD |
| Common Stock | 3,000USD | 3,000USD | 3,000USD | 3,000USD | 3,000USD | 3,000USD | 3,000USD | 3,000USD |
| Capital Stock | 3,000USD | 3,000USD | 3,000USD | 3,000USD | 3,000USD | 3,000USD | 3,000USD | 3,000USD |
| Retained Earnings | -356,999,000USD | -346,349,000USD | -336,781,000USD | -323,873,000USD | -313,487,000USD | -295,311,000USD | -279,110,000USD | -264,491,000USD |
| Cash | 36,626,000USD | 35,021,000USD | 32,496,000USD | 42,327,000USD | 64,717,000USD | 75,840,000USD | 77,014,000USD | 95,959,000USD |
| Cash And Short Term Investments | 104,539,000USD | 113,124,000USD | 116,693,000USD | 125,407,000USD | 144,569,000USD | 151,250,000USD | 152,486,000USD | 166,373,000USD |
| Total Current Assets | 107,716,000USD | 116,404,000USD | 119,233,000USD | 127,196,000USD | 146,072,000USD | 152,774,000USD | 157,190,000USD | 166,751,000USD |
| Total Current Liabilities | 5,297,000USD | 5,101,000USD | 9,146,000USD | 7,247,000USD | 7,180,000USD | 4,454,000USD | 4,092,000USD | 5,728,000USD |
| Net Debt | -36,587,000USD | -34,943,000USD | -32,381,000USD | -42,175,000USD | -64,678,000USD | -75,762,000USD | -76,898,000USD | -95,806,000USD |
| Short Term Debt | 39,000USD | 78,000USD | 115,000USD | 152,000USD | 39,000USD | 78,000USD | 116,000USD | 153,000USD |
| Short Long Term Debt Total | 39,000USD | 78,000USD | 115,000USD | 152,000USD | 39,000USD | 78,000USD | 116,000USD | 153,000USD |
| Short Term Investments | 67,913,000USD | 78,103,000USD | 84,197,000USD | 83,080,000USD | 79,852,000USD | 75,410,000USD | 75,472,000USD | 70,414,000USD |
| Accounts Payable | 2,303,000USD | 1,309,000USD | 4,243,000USD | 1,921,000USD | 3,223,000USD | 1,425,000USD | 1,152,000USD | 1,994,000USD |
| Property Plant Equipment Net | 39,000USD | 78,000USD | 115,000USD | 152,000USD | 38,000USD | 77,000USD | 114,000USD | 151,000USD |
| Property Plant Equipment Gross | 39,000USD | 78,000USD | 115,000USD | 152,000USD | 38,000USD | 77,000USD | 114,000USD | 151,000USD |
| Accumulated Other Comprehensive Income | 8,000USD | 120,000USD | 117,000USD | 76,000USD | 121,000USD | 230,000USD | 441,000USD | -23,000USD |
| Common Stock Shares Outstanding | 32,559,704shares | 32,345,525shares | 32,464,893shares | 32,195,366shares | 32,195,345shares | 32,195,345shares | 32,143,336shares | 31,913,887shares |
| Non Current Assets Total | 39,000USD | 78,000USD | 9,168,000USD | 10,211,000USD | 100,000USD | 7,485,000USD | 17,585,000USD | 22,269,000USD |
| Non Current Liabilities Total | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 3,581,000USD |
| Net Working Capital | 102,419,000USD | 111,303,000USD | 110,334,000USD | 119,949,000USD | 138,892,000USD | 148,320,000USD | 153,098,000USD | 161,023,000USD |
| Unclassified Equity | 459,443,000USD | 457,604,000USD | 455,913,000USD | 453,951,000USD | 452,352,000USD | 450,880,000USD | 449,346,000USD | 447,800,000USD |
| Long Term Investments | — | 0USD | 8,806,000USD | 10,059,000USD | 0USD | 7,408,000USD | 17,471,000USD | 22,118,000USD |
| Non Currrent Assets Other | — | — | 247,000USD | — | 62,000USD | 306,000USD | — | — |
| Other Assets | — | — | — | — | — | -306,000USD | — | — |
| Current Deferred Revenue | — | — | — | — | — | — | — | -153,000USD |
| Unclassified Non Current Liabilities | — | — | — | — | — | — | — | 3,581,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD |
|---|---|---|---|---|---|---|---|
| Total Assets | 116,482,000USD | 160,259,000USD | 96,719,000USD | 33,031,000USD | 59,032,000USD | 68,959,000USD | 11,160,000USD |
| Other Current Assets | 3,280,000USD | 1,524,000USD | 1,749,000USD | 447,000USD | 1,932,000USD | 36,000USD | 603,000USD |
| Total Liab | 5,101,000USD | 4,454,000USD | 5,654,000USD | 219,981,000USD | 217,291,000USD | 204,869,000USD | 136,475,000USD |
| Total Stockholder Equity | 111,381,000USD | 155,805,000USD | 91,065,000USD | -186,950,000USD | -158,259,000USD | -135,910,000USD | -125,315,000USD |
| Other Current Liab | 3,714,000USD | 2,951,000USD | 5,403,000USD | 4,021,000USD | 1,555,000USD | 1,252,000USD | 747,000USD |
| Common Stock | 3,000USD | 3,000USD | 2,000USD | 1,000USD | 1,000USD | 1,000USD | 1,000USD |
| Capital Stock | 3,000USD | 3,000USD | 2,000USD | 1,000USD | 1,000USD | 1,000USD | 1,000USD |
| Retained Earnings | -346,349,000USD | -295,311,000USD | -249,744,000USD | -221,868,000USD | -191,369,000USD | -166,927,000USD | -155,557,000USD |
| Cash | 35,021,000USD | 75,840,000USD | 75,139,000USD | 158,000USD | 56,731,000USD | 68,702,000USD | 10,212,000USD |
| Cash And Short Term Investments | 113,124,000USD | 151,250,000USD | 94,897,000USD | 32,345,000USD | 56,731,000USD | 68,702,000USD | 10,212,000USD |
| Total Current Assets | 116,404,000USD | 152,774,000USD | 96,646,000USD | 32,792,000USD | 58,663,000USD | 68,738,000USD | 10,815,000USD |
| Total Current Liabilities | 5,101,000USD | 4,454,000USD | 5,654,000USD | 5,279,000USD | 2,440,000USD | 1,910,000USD | 2,076,000USD |
| Net Debt | -34,943,000USD | -75,762,000USD | -75,074,000USD | 53,000USD | -56,383,000USD | -68,492,000USD | -9,871,000USD |
| Short Term Debt | 78,000USD | 78,000USD | 65,000USD | 133,000USD | 124,000USD | 145,000USD | 130,000USD |
| Short Long Term Debt Total | 78,000USD | 78,000USD | 65,000USD | 211,000USD | 348,000USD | 210,000USD | 341,000USD |
| Long Term Investments | 0USD | 7,408,000USD | 0USD | — | — | — | — |
| Short Term Investments | 78,103,000USD | 75,410,000USD | 19,758,000USD | 32,187,000USD | 0USD | — | — |
| Accounts Payable | 1,309,000USD | 1,425,000USD | 186,000USD | 1,125,000USD | 761,000USD | 513,000USD | 1,199,000USD |
| Property Plant Equipment Net | 78,000USD | 77,000USD | 73,000USD | 212,000USD | 342,000USD | 194,000USD | 318,000USD |
| Property Plant Equipment Gross | 78,000USD | 77,000USD | 73,000USD | 212,000USD | 342,000USD | 194,000USD | 318,000USD |
| Accumulated Other Comprehensive Income | 120,000USD | 230,000USD | 30,000USD | -84,000USD | -214,627,000USD | -202,894,000USD | 0USD |
| Common Stock Shares Outstanding | 32,345,525shares | 31,350,725shares | 18,194,682shares | 22,174,066shares | 22,174,066shares | 22,174,066shares | 22,174,066shares |
| Non Current Assets Total | 78,000USD | 7,485,000USD | 73,000USD | 239,000USD | 369,000USD | 221,000USD | 345,000USD |
| Non Current Liabilities Total | 0USD | 0USD | 0USD | 214,702,000USD | 214,851,000USD | 202,959,000USD | 134,399,000USD |
| Net Working Capital | 111,303,000USD | 148,320,000USD | 90,992,000USD | 27,513,000USD | 56,223,000USD | 66,828,000USD | 8,739,000USD |
| Unclassified Equity | 457,604,000USD | 450,880,000USD | 340,775,000USD | 35,000,000USD | 247,735,000USD | 233,909,000USD | 30,240,000USD |
| Non Currrent Assets Other | — | 7,408,000USD | — | 27,000USD | 27,000USD | 27,000USD | 27,000USD |
| Unclassified Non Current Assets | — | -7,408,000USD | — | — | — | — | — |
| Current Deferred Revenue | — | — | 5,170,000USD | 3,964,000USD | 1,370,000USD | 1,009,000USD | — |
| Unclassified Current Liabilities | — | — | -5,170,000USD | -3,964,000USD | -1,370,000USD | -1,009,000USD | — |
| Unclassified Non Current Liabilities | — | — | — | 214,702,000USD | 214,851,000USD | 202,959,000USD | 134,399,000USD |
| Other Assets | — | — | — | — | — | 27,000USD | 27,000USD |
| Net Tangible Assets | — | — | — | — | — | -135,910,000USD | -125,315,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -10,650,000USD | -9,568,000USD | -12,908,000USD | -10,386,000USD | -18,176,000USD | -16,201,000USD | -14,619,000USD | -8,118,000USD |
| Stock Based Compensation | 1,839,000USD | 1,691,000USD | 1,688,000USD | 1,598,000USD | 1,472,000USD | 1,534,000USD | 1,546,000USD | 1,449,000USD |
| Other Non Cash Items | 1,738,000USD | 337,000USD | 339,000USD | -188,000USD | 2,894,000USD | -19,000USD | -6,291,000USD | -442,000USD |
| Change In Working Capital | 301,000USD | -4,293,000USD | 701,000USD | -125,000USD | -726,000USD | 3,662,000USD | -205,000USD | 1,477,000USD |
| Total Cash From Operating Activities | -8,611,000USD | -11,833,000USD | -10,180,000USD | -9,101,000USD | -14,536,000USD | -11,024,000USD | -19,569,000USD | -5,634,000USD |
| Capital Expenditures | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Free Cash Flow | -8,611,000USD | -11,833,000USD | -10,180,000USD | -9,101,000USD | -14,536,000USD | -11,024,000USD | -19,569,000USD | -5,634,000USD |
| Investments | 10,216,000USD | 14,358,000USD | 75,000USD | -13,290,000USD | 3,413,000USD | 9,850,000USD | 624,000USD | -75,157,000USD |
| Total Cashflows From Investing Activities | 10,216,000USD | 14,358,000USD | 75,000USD | -13,290,000USD | 3,413,000USD | 9,850,000USD | 624,000USD | -75,157,000USD |
| Change In Cash | 1,605,000USD | 2,525,000USD | -9,831,000USD | -22,390,000USD | -11,123,000USD | -1,174,000USD | -18,945,000USD | -80,818,000USD |
| Begin Period Cash Flow | 35,021,000USD | 32,496,000USD | 42,327,000USD | 64,717,000USD | 75,840,000USD | 77,014,000USD | 95,959,000USD | 176,777,000USD |
| End Period Cash Flow | 36,626,000USD | 35,021,000USD | 32,496,000USD | 42,327,000USD | 64,717,000USD | 75,840,000USD | 77,014,000USD | 95,959,000USD |
| Unclassified Operating Cash Flow | -1,839,000USD | — | — | — | — | — | — | — |
| Total Cash From Financing Activities | — | 0USD | 274,000USD | 1,000USD | 0USD | 0USD | 0USD | -27,000USD |
| Issuance Of Capital Stock | — | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Other Cashflows From Financing Activities | — | 275,000USD | — | — | — | 105,750,000USD | 624,000USD | -27,000USD |
| Unclassified Financing Cash Flow | — | — | — | — | — | -105,750,000USD | — | — |
| Other Cashflows From Investing Activities | — | — | — | — | — | — | 82,952,000USD | -75,157,000USD |
| Unclassified Investing Cash Flow | — | — | — | — | — | — | -82,952,000USD | 75,157,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD |
|---|---|---|---|---|---|---|---|
| Net Income | -51,038,000USD | -45,567,000USD | -27,876,000USD | -30,499,000USD | -24,442,000USD | -11,370,000USD | -14,261,000USD |
| Stock Based Compensation | 6,449,000USD | 5,288,000USD | 4,990,000USD | 1,880,000USD | 1,904,000USD | 775,000USD | 2,988,000USD |
| Other Non Cash Items | -8,000USD | -1,108,000USD | 98,000USD | -215,000USD | 883,000USD | 104,000USD | 75,000USD |
| Change In Working Capital | -1,053,000USD | -1,048,000USD | -978,000USD | 4,214,000USD | -55,000USD | 75,000USD | 645,000USD |
| Total Cash From Operating Activities | -45,650,000USD | -42,435,000USD | -23,766,000USD | -24,490,000USD | -21,710,000USD | -10,416,000USD | -10,552,000USD |
| Capital Expenditures | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Free Cash Flow | -45,650,000USD | -42,435,000USD | -23,766,000USD | -24,490,000USD | -21,710,000USD | -10,416,000USD | -10,552,000USD |
| Investments | 4,556,000USD | -61,683,000USD | 37,636,000USD | -32,010,000USD | 0USD | 20,000USD | -27,000USD |
| Total Cashflows From Investing Activities | 4,556,000USD | -61,683,000USD | 12,580,000USD | -32,010,000USD | — | 20,000USD | -27,000USD |
| Total Cash From Financing Activities | 275,000USD | 104,819,000USD | 86,167,000USD | -73,000USD | 9,739,000USD | 68,886,000USD | 18,485,000USD |
| Issuance Of Capital Stock | 0USD | 105,750,000USD | 86,161,000USD | 0USD | 10,804,000USD | 68,886,000USD | 21,849,000USD |
| Change In Cash | -40,819,000USD | 701,000USD | 74,981,000USD | -56,573,000USD | -11,971,000USD | 58,490,000USD | 7,906,000USD |
| Begin Period Cash Flow | 75,840,000USD | 75,139,000USD | 158,000USD | 56,731,000USD | 68,702,000USD | 10,212,000USD | 2,306,000USD |
| End Period Cash Flow | 35,021,000USD | 75,840,000USD | 75,139,000USD | 158,000USD | 56,731,000USD | 68,702,000USD | 10,212,000USD |
| Other Cashflows From Financing Activities | 275,000USD | -931,000USD | -3,512,000USD | -85,000USD | 9,739,000USD | 68,886,000USD | 21,849,000USD |
| Unclassified Investing Cash Flow | — | — | -25,056,000USD | 32,010,000USD | — | — | — |
| Unclassified Financing Cash Flow | — | — | 3,518,000USD | — | -10,804,000USD | -68,886,000USD | -21,849,000USD |
| Depreciation | — | — | — | 130,000USD | 134,000USD | 124,000USD | 1,000USD |
| Other Cashflows From Investing Activities | — | — | — | -32,010,000USD | — | 20,000USD | -27,000USD |
| Change To Liabilities | — | — | — | — | — | -361,000USD | 1,278,000USD |
| Net Borrowings | — | — | — | — | — | — | -3,364,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
No revenue breakdown is currently published for this company.
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.